Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
TREACE MEDICAL CONCEPTS, INC. Treace Medical Concepts, Inc. Stock price
Equities
TMCI
US89455T1097
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 9.310 USD | +6.28% | +4.96% | -59.50% | |
Financials (USD)
| Sales 2023 * | 184 M | Sales 2024 * | 221 M | Capitalization | 574 M |
|---|---|---|---|---|---|
| Net income 2023 * | -49.00 M | Net income 2024 * | -35.00 M | EV / Sales 2023 * | 2,90x |
| Net cash position 2023 * | 41.40 M | Net Debt 2024 * | 7.65 M | EV / Sales 2024 * | 2,63x |
| P/E ratio 2023 * | -11,6x | P/E ratio 2024 * | -14,6x | Employees | 423 |
| Yield 2023 * | - | Yield 2024 * | - | Free-Float | 68.19% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | +6.28% | ||
| 1 week | +4.96% | ||
| Current month | +6.28% | ||
| 1 month | -13.15% | ||
| 3 months | -40.21% | ||
| 6 months | -65.24% | ||
| Current year | -59.50% |
1 week
8.44
9.38
1 month
5.2711.48
Current year
5.2727.97
1 year
5.2727.97
3 years
5.2737.17
5 years
5.2737.17
10 years
5.2737.17
| Managers | Title | Age | Since |
|---|---|---|---|
John T. Treace
FOU | Founder | 51 | 2013 |
Mark L. Hair
DFI | Director of Finance/CFO | 53 | 2020 |
Scot Elder
CMP | Compliance Officer | 48 | 2022 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2020 | |
Richard Mott
BRD | Director/Board Member | 64 | 2015 |
James T. Treace
CHM | Chairman | 77 | 2014 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.02% | 277 M€ | -14.67% | - | |
| 0.84% | 4 M€ | -.--% | ||
| 0.28% | 36 M€ | -8.21% | - | |
| 0.23% | 188 M€ | +6.49% | ||
| 0.23% | 6 M€ | +11.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-01 | 9.310 | +6.28% | 753,533 |
| 23-11-30 | 8.760 | -2.34% | 2,210,028 |
| 23-11-29 | 8.970 | +3.34% | 1,149,057 |
| 23-11-28 | 8.680 | -1.70% | 2,203,213 |
| 23-11-27 | 8.830 | -0.45% | 1,478,787 |
Delayed Quote Nasdaq, December 01, 2023 at 04:00 pm EST
More quotes
Treace Medical Concepts, Inc. is a medical technology company. The Company's Lapiplasty three-dimensional (3D) Bunion Correction System is a combination of instruments, implants and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. The Lapiplasty System combines its novel surgical approach, the Lapiplasty Procedure, with its procedural instrumentation and single-use implant kits. The Company is also providing Adductoplasty Midfoot Correction System, designed for reproducible correction of the midfoot to provide further support to hallux valgus patients. The Lapiplasty and Adductoplasty Systems are comprised of single-use implant kits and reusable instrument trays. The Company also commercialized new products that address ancillary surgical procedures performed routinely in connection with the Lapiplasty Procedure.
Calendar
2024-02-28
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
9.310USD
Average target price
13.29USD
Spread / Average Target
+42.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -59.50% | 574 M $ | |
| +2.38% | 8 790 M $ | |
| -11.39% | 6 723 M $ | |
| +4.81% | 5 947 M $ | |
| +30.82% | 5 223 M $ | |
| -34.63% | 5 110 M $ | |
| +6.06% | 4 684 M $ | |
| -3.71% | 3 525 M $ | |
| +23.06% | 3 521 M $ | |
| -27.16% | 2 437 M $ |
